Bleeding Disorders Treatment Market Projected To Reach USD 35.17 Billion By 2032, Growing At A Robust CAGR Of 8.91%
Driven by Biopharmaceutical Innovations and Gene Therapies, the market Booms Amidst Growing Incidence of Hemophilia and Von Willebrand Disease ...